Study #2024-0505
Phase 1 trial of the safety, pharmacokinetics, pharmacodynamics, and preliminary clinical activity of RP-3467 alone and in combination with Olaparib in participants with advanced solid tumors (POLAR Trial)
MD Anderson Study Status
Enrolling
Treatment Agent
Description
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Study phase:
Physician name:
Timothy Yap
Department:
Investigational Cancer Therapeutics
For general questions about clinical trials:
1-877-734-0338
Help #EndCancer
Give Now
Your gift will help make a tremendous difference.
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.